Industry Research Reports

Home > Reports > Medical Devices & Consumables > Lung Tumor Ablation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Lung Tumor Ablation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Medical Devices & Consumables

Published Date: 2026-06-16

Pages: 118 Pages

Report ld: 6748894

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Lung Tumor Ablation Market Size(US$)

CAGR 2026-2032

9.3%

Market Size,2032

USD 4,480

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 2,627 million

Market Forecast in 2032(Value)

US$ 4,480 million

CAGR

9.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Lung Tumor Ablation was estimated to be worth US$ 2425 million in 2025 and is projected to reach US$ 4480 million, growing at a CAGR of 9.3% from 2026 to 2032.

Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report provides a comprehensive view of the global market for Lung Tumor Ablation, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Lung Tumor Ablation market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Lung Tumor Ablation.

MARKET SEGMENTATION

By Company

Medtronic
Olympus
LungCare
Broncus
Intuitive Surgica
Auris Health
Angiodynamics
Boston Scientific
Smith and Nephew
VISON Medical
Nanjing MICRO-TECH
TIPC

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Radiofrequency Ablation (RFA)
Microwave Ablation (MWA)
Cold Ablation
Others

Segment by Application

Hospitals
Ambulatory Surgical Centers

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Lung Tumor Ablation companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Lung Tumor Ablation revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Lung Tumor Ablation revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Lung Tumor Ablation Product Introduction

1.2 Global Lung Tumor Ablation Market Size Forecast (2021–2032)

1.3 Lung Tumor Ablation Market Trends & Drivers

1.3.1 Lung Tumor Ablation Industry Trends

1.3.2 Lung Tumor Ablation Market Drivers & Opportunities

1.3.3 Lung Tumor Ablation Market Challenges

1.3.4 Lung Tumor Ablation Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Lung Tumor Ablation Players Revenue Ranking (2025)

2.2 Global Lung Tumor Ablation Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Lung Tumor Ablation Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Lung Tumor Ablation

2.6 Lung Tumor Ablation Market Competitive Analysis

2.6.1 Lung Tumor Ablation Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Lung Tumor Ablation Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lung Tumor Ablation revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Lung Tumor Ablation Market Classification

3.1 Introduction by Type

3.1.1 Radiofrequency Ablation (RFA)

3.1.2 Microwave Ablation (MWA)

3.1.3 Cold Ablation

3.1.4 Others

3.1.5 Global Lung Tumor Ablation Sales Value by Type

3.1.5.1 Global Lung Tumor Ablation Sales Value by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Lung Tumor Ablation Sales Value, by Type (2021–2032)

3.1.5.3 Global Lung Tumor Ablation Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Ambulatory Surgical Centers

4.2 Global Lung Tumor Ablation Sales Value by Application

4.2.1 Global Lung Tumor Ablation Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Lung Tumor Ablation Sales Value by Application (2021–2032)

4.2.3 Global Lung Tumor Ablation Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Lung Tumor Ablation Sales Value by Region

5.1.1 Global Lung Tumor Ablation Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Lung Tumor Ablation Sales Value by Region (2021–2026)

5.1.3 Global Lung Tumor Ablation Sales Value by Region (2027–2032)

5.1.4 Global Lung Tumor Ablation Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Lung Tumor Ablation Sales Value, 2021–2032

5.2.2 North America Lung Tumor Ablation Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Lung Tumor Ablation Sales Value, 2021–2032

5.3.2 Europe Lung Tumor Ablation Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Lung Tumor Ablation Sales Value, 2021–2032

5.4.2 Asia Pacific Lung Tumor Ablation Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Lung Tumor Ablation Sales Value, 2021–2032

5.5.2 South America Lung Tumor Ablation Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Lung Tumor Ablation Sales Value, 2021–2032

5.6.2 Middle East & Africa Lung Tumor Ablation Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Lung Tumor Ablation Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Lung Tumor Ablation Sales Value, 2021–2032

6.3 United States

6.3.1 United States Lung Tumor Ablation Sales Value, 2021–2032

6.3.2 United States Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Lung Tumor Ablation Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Lung Tumor Ablation Sales Value, 2021–2032

6.4.2 Europe Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Lung Tumor Ablation Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Lung Tumor Ablation Sales Value, 2021–2032

6.5.2 China Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

6.5.3 China Lung Tumor Ablation Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Lung Tumor Ablation Sales Value, 2021–2032

6.6.2 Japan Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Lung Tumor Ablation Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Lung Tumor Ablation Sales Value, 2021–2032

6.7.2 South Korea Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Lung Tumor Ablation Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Lung Tumor Ablation Sales Value, 2021–2032

6.8.2 Southeast Asia Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Lung Tumor Ablation Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Lung Tumor Ablation Sales Value, 2021–2032

6.9.2 India Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

6.9.3 India Lung Tumor Ablation Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Medtronic

7.1.1 Medtronic Profile

7.1.2 Medtronic Main Business

7.1.3 Medtronic Lung Tumor Ablation Products, Services, and Solutions

7.1.4 Medtronic Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.1.5 Medtronic Recent Developments

7.2 Olympus

7.2.1 Olympus Profile

7.2.2 Olympus Main Business

7.2.3 Olympus Lung Tumor Ablation Products, Services, and Solutions

7.2.4 Olympus Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.2.5 Olympus Recent Developments

7.3 LungCare

7.3.1 LungCare Profile

7.3.2 LungCare Main Business

7.3.3 LungCare Lung Tumor Ablation Products, Services, and Solutions

7.3.4 LungCare Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.3.5 LungCare Recent Developments

7.4 Broncus

7.4.1 Broncus Profile

7.4.2 Broncus Main Business

7.4.3 Broncus Lung Tumor Ablation Products, Services, and Solutions

7.4.4 Broncus Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.4.5 Broncus Recent Developments

7.5 Intuitive Surgica

7.5.1 Intuitive Surgica Profile

7.5.2 Intuitive Surgica Main Business

7.5.3 Intuitive Surgica Lung Tumor Ablation Products, Services, and Solutions

7.5.4 Intuitive Surgica Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.5.5 Intuitive Surgica Recent Developments

7.6 Auris Health

7.6.1 Auris Health Profile

7.6.2 Auris Health Main Business

7.6.3 Auris Health Lung Tumor Ablation Products, Services, and Solutions

7.6.4 Auris Health Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.6.5 Auris Health Recent Developments

7.7 Angiodynamics

7.7.1 Angiodynamics Profile

7.7.2 Angiodynamics Main Business

7.7.3 Angiodynamics Lung Tumor Ablation Products, Services, and Solutions

7.7.4 Angiodynamics Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.7.5 Angiodynamics Recent Developments

7.8 Boston Scientific

7.8.1 Boston Scientific Profile

7.8.2 Boston Scientific Main Business

7.8.3 Boston Scientific Lung Tumor Ablation Products, Services, and Solutions

7.8.4 Boston Scientific Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.8.5 Boston Scientific Recent Developments

7.9 Smith and Nephew

7.9.1 Smith and Nephew Profile

7.9.2 Smith and Nephew Main Business

7.9.3 Smith and Nephew Lung Tumor Ablation Products, Services, and Solutions

7.9.4 Smith and Nephew Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.9.5 Smith and Nephew Recent Developments

7.10 VISON Medical

7.10.1 VISON Medical Profile

7.10.2 VISON Medical Main Business

7.10.3 VISON Medical Lung Tumor Ablation Products, Services, and Solutions

7.10.4 VISON Medical Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.10.5 VISON Medical Recent Developments

7.11 Nanjing MICRO-TECH

7.11.1 Nanjing MICRO-TECH Profile

7.11.2 Nanjing MICRO-TECH Main Business

7.11.3 Nanjing MICRO-TECH Lung Tumor Ablation Products, Services, and Solutions

7.11.4 Nanjing MICRO-TECH Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.11.5 Nanjing MICRO-TECH Recent Developments

7.12 TIPC

7.12.1 TIPC Profile

7.12.2 TIPC Main Business

7.12.3 TIPC Lung Tumor Ablation Products, Services, and Solutions

7.12.4 TIPC Lung Tumor Ablation Revenue (US$ Million), 2021–2026

7.12.5 TIPC Recent Developments

8 Industry Chain Analysis

8.1 Lung Tumor Ablation Value Chain

8.2 Lung Tumor Ablation Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Lung Tumor Ablation Sales Model

8.5.2 Sales Channels

8.5.3 Lung Tumor Ablation Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Lung Tumor Ablation Market Trends

Table 2. Lung Tumor Ablation Market Drivers & Opportunities

Table 3. Lung Tumor Ablation Market Challenges

Table 4. Lung Tumor Ablation Market Restraints

Table 5. Global Lung Tumor Ablation Revenue by Company (US$ Million), 2021–2026

Table 6. Global Lung Tumor Ablation Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Lung Tumor Ablation Product Type

Table 9. Key Companies General Availability (GA) Timeline for Lung Tumor Ablation

Table 10. Global Lung Tumor Ablation Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lung Tumor Ablation revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Lung Tumor Ablation Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Lung Tumor Ablation Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Lung Tumor Ablation Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Lung Tumor Ablation Sales Market Share in Value by Type (2021–2026)

Table 17. Global Lung Tumor Ablation Sales Market Share in Value by Type (2027–2032)

Table 18. Global Lung Tumor Ablation Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Lung Tumor Ablation Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Lung Tumor Ablation Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Lung Tumor Ablation Sales Market Share in Value by Application (2021–2026)

Table 22. Global Lung Tumor Ablation Sales Market Share in Value by Application (2027–2032)

Table 23. Global Lung Tumor Ablation Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Lung Tumor Ablation Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Lung Tumor Ablation Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Lung Tumor Ablation Sales Value by Region (%), 2021–2026

Table 27. Global Lung Tumor Ablation Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Lung Tumor Ablation Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Lung Tumor Ablation Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Lung Tumor Ablation Sales Value, (US$ Million), 2027–2032

Table 31. Medtronic Basic Information List

Table 32. Medtronic Description and Business Overview

Table 33. Medtronic Lung Tumor Ablation Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Lung Tumor Ablation Business of Medtronic (2021–2026)

Table 35. Medtronic Recent Developments

Table 36. Olympus Basic Information List

Table 37. Olympus Description and Business Overview

Table 38. Olympus Lung Tumor Ablation Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Lung Tumor Ablation Business of Olympus (2021–2026)

Table 40. Olympus Recent Developments

Table 41. LungCare Basic Information List

Table 42. LungCare Description and Business Overview

Table 43. LungCare Lung Tumor Ablation Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Lung Tumor Ablation Business of LungCare (2021–2026)

Table 45. LungCare Recent Developments

Table 46. Broncus Basic Information List

Table 47. Broncus Description and Business Overview

Table 48. Broncus Lung Tumor Ablation Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Lung Tumor Ablation Business of Broncus (2021–2026)

Table 50. Broncus Recent Developments

Table 51. Intuitive Surgica Basic Information List

Table 52. Intuitive Surgica Description and Business Overview

Table 53. Intuitive Surgica Lung Tumor Ablation Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Lung Tumor Ablation Business of Intuitive Surgica (2021–2026)

Table 55. Intuitive Surgica Recent Developments

Table 56. Auris Health Basic Information List

Table 57. Auris Health Description and Business Overview

Table 58. Auris Health Lung Tumor Ablation Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Lung Tumor Ablation Business of Auris Health (2021–2026)

Table 60. Auris Health Recent Developments

Table 61. Angiodynamics Basic Information List

Table 62. Angiodynamics Description and Business Overview

Table 63. Angiodynamics Lung Tumor Ablation Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Lung Tumor Ablation Business of Angiodynamics (2021–2026)

Table 65. Angiodynamics Recent Developments

Table 66. Boston Scientific Basic Information List

Table 67. Boston Scientific Description and Business Overview

Table 68. Boston Scientific Lung Tumor Ablation Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Lung Tumor Ablation Business of Boston Scientific (2021–2026)

Table 70. Boston Scientific Recent Developments

Table 71. Smith and Nephew Basic Information List

Table 72. Smith and Nephew Description and Business Overview

Table 73. Smith and Nephew Lung Tumor Ablation Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Lung Tumor Ablation Business of Smith and Nephew (2021–2026)

Table 75. Smith and Nephew Recent Developments

Table 76. VISON Medical Basic Information List

Table 77. VISON Medical Description and Business Overview

Table 78. VISON Medical Lung Tumor Ablation Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Lung Tumor Ablation Business of VISON Medical (2021–2026)

Table 80. VISON Medical Recent Developments

Table 81. Nanjing MICRO-TECH Basic Information List

Table 82. Nanjing MICRO-TECH Description and Business Overview

Table 83. Nanjing MICRO-TECH Lung Tumor Ablation Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Lung Tumor Ablation Business of Nanjing MICRO-TECH (2021–2026)

Table 85. Nanjing MICRO-TECH Recent Developments

Table 86. TIPC Basic Information List

Table 87. TIPC Description and Business Overview

Table 88. TIPC Lung Tumor Ablation Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Lung Tumor Ablation Business of TIPC (2021–2026)

Table 90. TIPC Recent Developments

Table 91. Revenue (US$ Million) in Lung Tumor Ablation Business of Company 40 (2021–2026)

Table 92. Company 40 Recent Developments

Table 93. Key Raw Materials Lists

Table 94. Key Suppliers of Raw Materials Lists

Table 95. Lung Tumor Ablation Downstream Customers

Table 96. Lung Tumor Ablation Distributors List

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Lung Tumor Ablation Product Picture

Figure 2. Global Lung Tumor Ablation Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 4. Lung Tumor Ablation Report Years Considered

Figure 5. Global Lung Tumor Ablation Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Lung Tumor Ablation Revenue in 2025

Figure 7. Lung Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Radiofrequency Ablation (RFA) Picture

Figure 9. Microwave Ablation (MWA) Picture

Figure 10. Cold Ablation Picture

Figure 11. Others Picture

Figure 12. Global Lung Tumor Ablation Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Lung Tumor Ablation Sales Value Market Share by Type, 2025 & 2032

Figure 14. Product Picture of Hospitals

Figure 15. Product Picture of Ambulatory Surgical Centers

Figure 16. Global Lung Tumor Ablation Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Lung Tumor Ablation Sales Value Market Share by Application, 2025 & 2032

Figure 18. North America Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 19. North America Lung Tumor Ablation Sales Value by Country (%), 2025 vs 2032

Figure 20. Europe Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 21. Europe Lung Tumor Ablation Sales Value by Country (%), 2025 vs 2032

Figure 22. Asia Pacific Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 23. Asia Pacific Lung Tumor Ablation Sales Value by Subregion (%), 2025 vs 2032

Figure 24. South America Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 25. South America Lung Tumor Ablation Sales Value by Country (%), 2025 vs 2032

Figure 26. Middle East & Africa Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 27. Middle East & Africa Lung Tumor Ablation Sales Value by Country (%), 2025 vs 2032

Figure 28. Key Countries/Regions Lung Tumor Ablation Sales Value (%), 2021–2032

Figure 29. United States Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 30. United States Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

Figure 31. United States Lung Tumor Ablation Sales Value by Application (%), 2025 vs 2032

Figure 32. Europe Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 33. Europe Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

Figure 34. Europe Lung Tumor Ablation Sales Value by Application (%), 2025 vs 2032

Figure 35. China Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 36. China Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

Figure 37. China Lung Tumor Ablation Sales Value by Application (%), 2025 vs 2032

Figure 38. Japan Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 39. Japan Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

Figure 40. Japan Lung Tumor Ablation Sales Value by Application (%), 2025 vs 2032

Figure 41. South Korea Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 42. South Korea Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

Figure 43. South Korea Lung Tumor Ablation Sales Value by Application (%), 2025 vs 2032

Figure 44. Southeast Asia Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 45. Southeast Asia Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

Figure 46. Southeast Asia Lung Tumor Ablation Sales Value by Application (%), 2025 vs 2032

Figure 47. India Lung Tumor Ablation Sales Value (US$ Million), 2021–2032

Figure 48. India Lung Tumor Ablation Sales Value by Type (%), 2025 vs 2032

Figure 49. India Lung Tumor Ablation Sales Value by Application (%), 2025 vs 2032

Figure 50. Lung Tumor Ablation Value Chain

Figure 51. Lung Tumor Ablation Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Lung Tumor Ablation in 2026? zhanKai

The global market size of Lung Tumor Ablation in 2026 was 2627 Million USD.

What was the global market size of Lung Tumor Ablation in 2032? shouQi

What is the annual compound growth rate of the global Lung Tumor Ablation market size from 2026 to 2032? shouQi

Which companies rank high in the global Lung Tumor Ablation market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Lung Tumor Ablation Market Research Report 2026
The global Lung Tumor Ablation market was valued at US$ 2425 million in 2025 and is anticipated to reach US$ 4480 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 117
USD 2900.00
(Single User License)
Global Lung Tumor Ablation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Tumor Ablation market size was US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 94
USD 4250.00
(Single User License)
Global Lung Tumor Ablation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Tumor Ablation market is projected to grow from US$ 2237 million in 2024 to US$ 4134 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-02
Pages: 136
USD 4900.00
(Single User License)
Lung Tumor Ablation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Tumor Ablation was estimated to be worth US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 117
USD 3950.00
(Single User License)
Global Lung Tumor Ablation Market Research Report 2025
The global market for Lung Tumor Ablation was valued at US$ 2237 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Global Lung Tumor Ablation Market Insights, Forecast to 2030
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published Date: 2024-04-15
Pages: 107
USD 4900.00
(Single User License)
Global Lung Tumor Ablation Market Research Report 2024
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published Date: 2024-01-18
Pages: 86
USD 2900.00
(Single User License)

Global Lung Tumor Ablation Market Research Report 2026
The global Lung Tumor Ablation market was valued at US$ 2425 million in 2025 and is anticipated to reach US$ 4480 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-04-17
Pages: 117
USD 2900.00 (Single User License)
Global Lung Tumor Ablation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Tumor Ablation market size was US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 94
USD 4250.00 (Single User License)
Global Lung Tumor Ablation Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lung Tumor Ablation market is projected to grow from US$ 2237 million in 2024 to US$ 4134 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 136
USD 4900.00 (Single User License)
Lung Tumor Ablation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Tumor Ablation was estimated to be worth US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 117
USD 3950.00 (Single User License)
Global Lung Tumor Ablation Market Research Report 2025
The global market for Lung Tumor Ablation was valued at US$ 2237 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published: 2025-01-13
Pages: 90
USD 2900.00 (Single User License)
Global Lung Tumor Ablation Market Insights, Forecast to 2030
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published: 2024-04-15
Pages: 107
USD 4900.00 (Single User License)
Global Lung Tumor Ablation Market Research Report 2024
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published: 2024-01-18
Pages: 86
USD 2900.00 (Single User License)